Biodesix, Inc. - Common Stock (BDSX)

The US market session of Monday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Let's have a look at the gap up and gap down stocks in today's session.

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Curious about the most active stocks in today's session? Get a glimpse into the stocks that are generating the highest trading volume and capturing market attention.

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

U.S. stock futures were swinging on Thursday following Wednesday's mixed moves. Futures of major benchmark indices were mixed.

Biodesix shares surged over 51% in after-hours trading after major shareholder Jack W. Schuler disclosed a $1.5 million insider stock purchase.

As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

As the regular session of the US market concludes on Friday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Investors cheered a 4.7 million share insider purchase and rallied behind the company’s push toward Q4 EBITDA positivity, offsetting Scotiabank’s price target cut to $2 after a Q1 revenue miss and lowered 2025 guidance.